Determining medical decision-making capacity in brain tumor patients: why and how? European Association of Neuro-Oncology Palliative Care Task Force
Brain tumor patients are at high risk of impaired medical decision-making capacity (MDC), which can be ethically challenging because it limits their ability to give informed consent to medical treatments or participation in research. The European Association of Neuro-Oncology Palliative Care Multidisciplinary Task Force performed a systematic review to identify relevant evidence with respect to MDC that could be used to give recommendations on how to cope with reduced MDC in brain tumor patients.
Click here to read published version (Neuro-Oncology Practice, 2020, npaa040, https://doi.org/10.1093/nop/npaa040)
Declarations of potential or actual conflicts of interest, whether due to a financial or other relationship, must be provided.
Declarations must include any payments, honorarium or arrangement for re-imbursement of expenses, relevant for any aspect of his/her involvement with EANO,
that has been provided by commercial companies.
Log in to edit your data
